AI-generated summary
The authors studied red and near-infrared light therapy in dystrophic mouse muscle cells and gastrocnemius muscle from mdx mice, a model of Duchenne muscular dystrophy. They report that the treatment at low doses lowered hydrogen peroxide production in cells without cytotoxicity, reduced TRPC-6 content, and raised PGC-1α content in the muscle. The authors suggest laser therapy could act as an auxiliary treatment, but the findings come from cell and animal experiments.
- Who or what was studied
- mdx mice (dystrophin-deficient model of Duchenne muscular dystrophy): primary dystrophic muscle cells and gastrocnemius muscle
- Limits stated in the abstract
- Findings are from in vitro cell and in vivo animal studies, and the abstract does not state sample sizes or wavelengths.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Total energy
- 0.6 J, 5 J
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Laser, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.